Monoclonal immunoglobulins and tbe measurement of inorganic pbosphate in serum
I read with interest the recent paper of Bowles et al.I on pseudohyperphosphataemia in patients with monoclonal paraproteins, and would fully endorse their conclusions on the clinical implications of such findings.? A recent review of the scattered previous reports of monoclonal paraprotein-associated pseudohyperphosphataernia confirmed the lack of any apparent association with particular immunoglobulin type or subclass.' The observation that paraprotein concentration is not related to presence or absence of interf'erence' is consistent with the report of Morin and Prox that addition of up to 50 giL of exogenous globulin did not interfere with the phosphomolybdate assay." It should be recalled, however, that mechanisms other than protein precipitation may be responsible for some cases of pseudohyperphosphataemia: some authors have not observed turbidity in the reaction mixturc.! and phosphate binding by the myeloma protein has been recorded in one case."
The phenomenon of paraprotein interference due to precipitation of monoclonal protein may be generally applicable to spectrophotometric assays. Such interference has been noted in spectrophotometric assays of chloride ion concentration (which influences measurement of anion gap),? glucose," and haemoglobm.v-" The fact that the prevalence of pseudohyperphosphataemia when looked for systematically is very much higher' than indicated by the paucity of case reports in the literature' suggests that a similar evaluation of other spectrophotometric assays may reveal paraprotein interference to be more common than currently thought. The findings of Bowles and colleagues may thus have an applicability wider than just inorganic phosphate measurements. ANDREW 1994; 47: 681 [Correction: J C/in Patho/ 1994; 47: 870] 
Measurement of 5-HIAA in urine
We would like to comment on the publication of Deacon, I who reviewed clinical chemical aspects of urinary 5-hydroxyindoleacetic acid (5-HIAA) and stated that 'the current consensus is that urinary 5-HIAA serves as the most consistent biochemical marker of the carcinoid syndrome but that there may be a role for the estimation of other indoles'. In our opinion, this statement does not give proper credit to the higher sensitivity of platelet serotonin (5-HT) as a biochemical marker for diagnosis of carcinoid tumours.
It has been established that certain carcinoid tumours give rise to elevated platelet 5-HT in the presence of normal urinary 5-HlAA. 2 -4 Recently, we used existing high performance liquid Ann Clin Biochem 1995: 32 
